Knowing where all our ingredients come from is the first step toward improving drug quality.

The State Children’s Health Insurance Program (SCHIP) pays a part of the cost of insurance coverage for millions of low-income children who are not eligible for Medicaid. Democratic leadership on Capitol Hill is promoting a substantial expansion in the scope and funding for the program, while the White House maintains...

If we are to improve health care, we need effective ways to measure how health care providers deliver care. Speakers at this conference will assess how existing physician performance measurement tools operate and how we can improve their accuracy, reliability, transparency, and usefulness. For example, both the Government Accountability Office...

In view of Michael Leavitt's nomination to head the Environmental Protection Agency, we thought you would be interested in the new AEI Public Opinion Study "Polls on the Environment."

Last week a major international health donor had to admit it had lost over two million dollars of medicines and $34 million in cash to corruption. But the situation is worse than publicly acknowledged and is set to deteriorate further.

Medicare is under intense scrutiny from the Democratic Congress, driven by recent policies that have increased program spending. The new Part D drug benefit is popular with seniors, but expensive to taxpayers. Democrats argue that the prices of Part D pharmaceuticals are too high and that direct government negotiation would...

Media inquiries: Veronique Rodman202.862.4870 (vrodman@aei.org)

FOR IMMEDIATE RELEASE: April 20, 2007

The following AEI scholars are available to comment on the annual Medicare Trustees' Report, to be released Monday, April 23, which provides the latest assessment of Medicare's fiscal future:

US/EU companies that protect their drug brands in turn protect our lives. We need other countries to do more and we need to help them in doing so.